medigraphic.com
ISSN 2448-5640 (Impreso)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2024, Número 1

<< Anterior Siguiente >>

Cir Card Mex 2024; 9 (1)


Optimización de los resultados en pacientes de alto riesgo con baja fracción de eyección del ventrículo izquierdo sometidos a injerto de derivación de arteria coronaria: informe de caso y revisión

De La Cerda-Belmonta GA, Garza-De La Mazab A, Cepeda-Floresc MG, Vázquez-Gonzáleza RM, Morales-Marína CA, Cruz-Ramosd F, Pedroza-Solisa E

Idioma: Ingles.
Referencias bibliográficas: 22
Paginas: 30-34
Archivo PDF: 223.55 Kb.


RESUMEN

El manejo de pacientes con cardiopatía isquémica y fracción de expulsión reducida continúa siendo todo un reto a pesar de los avances médicos. La revascularización miocárdica ha demostrado ser de beneficio para pacientes con fracción de expulsión reducida, sin embargo, no está libre de riesgos, tales como el síndrome de estado de choque post-cardiotomía. Para optimizar resultados, se recomiendan múltiples estrategias prequirúrgicas e intraoperatorias, tales como pre-acondicionamiento con levosimendan, revascularización miocárdica con derivación cardiopulmonar a corazón latiendo, revascularización miocárdica completa, soporte mecánico circulatorio de respaldo. El abordaje individualizado por un equipo multidisciplinario (Heart-Team) reduce significativamente los riesgos, maximizando los resultados en este tipo de pacientes.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Awan NI, Jan A, Rehman MU, Ayaz N. The effect of ejection fraction on mortalityin Coronary Artery Bypass Grafting (CABG) patients. Pak J Med Sci. 2020;36(7):1454-1459. doi: 10.12669/pjms.36.7.3266.

  2. Topkara VK, Cheema FH, Kesavaramanujam S, Mercando ML, Cheema AF,Namerow PB, Argenziano M, Naka Y, Oz MC, Esrig BC. Coronary artery bypassgrafting in patients with low ejection fraction. Circulation. 2005;112(9 Suppl):I344-50. doi: 10.1161/CIRCULATIONAHA.104.526277.

  3. Dalén M, Lund LH, Ivert T, Holzmann MJ, Sartipy U. Survival After CoronaryArtery Bypass Grafting in Patients with Preoperative Heart Failure and Preservedvs Reduced Ejection Fraction. JAMA Cardiol. 2016;1(5):530-8. doi: 10.1001/jamacardio.2016.1465.

  4. Veterans Administration Coronary Artery Bypass Surgery Cooperative StudyGroup. Eleven-year survival in the Veterans Administration randomized trial ofcoronary bypass surgery for stable angina. N Engl J Med. 1984;311(21):1333-9.doi: 10.1056/NEJM198411223112102.

  5. Petrie MC, Jhund PS, She L, et al; STICH Trial Investigators. Ten-Year OutcomesAfter Coronary Artery Bypass Grafting According to Age in Patients withHeart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the ExtendedFollow-Up of the STICH Trial (Surgical Treatment for Ischemic HeartFailure). Circulation. 2016;134(18):1314-1324. doi: 10.1161/CIRCULATIONAHA.116.024800.

  6. Jiménez-Rivera JJ, Álvarez-Castillo A, Ferrer-Rodríguez J, et al. Preconditioningwith levosimendan reduces postoperative low cardiac output in moderate-severesystolic dysfunction patients who will undergo elective coronary artery bypassgraft surgery: a cost-effective strategy. J Cardiothorac Surg. 2020;15(1):108. doi:10.1186/s13019-020-01140-z.

  7. Tong MZY, Weiss AJ, Bakaeen F, Soltesz EG. CABG in Failing Hearts: A Howto-Guide to Using Modern Mechanical Support as Backup. Innovations (Phila).2021;16(3):227-230. doi: 10.1177/15569845211016455.

  8. Ali JM, Abu-Omar Y. Mechanical support for high-risk coronary artery bypassgrafting. Indian J Thorac Cardiovasc Surg. 2018;34(Suppl 3):287-296. doi:10.1007/s12055-018-0740-1.

  9. Erkut B, Dag O, Kaygin MA, et al. On-pump beating-heart versus conventionalcoronary artery bypass grafting for revascularization in patients with severe leftventricular dysfunction: early outcomes. Can J Surg. 2013;56(6):398-404. doi:

  10. 10.1503/cjs.018412.10. Samuels L, Samuels M. Pump-Assisted Beating-Heart Coronary Artery BypassGrafting: The Pursuit of Perfection. J Clin Exp Cardiolog 8: 540. doi:10.4172/2155-9880.1000540.

  11. Dominici C, Salsano A, Nenna A, et al. On-pump beating-heart coronary arterybypass grafting in high-risk patients: A systematic review and meta-analysis. JCard Surg. 2020;35(8):1958-1978. doi: 10.1111/jocs.14780.

  12. Xia L, Ji Q, Song K, et al. Early clinical outcomes of on-pump beating-heart versusoff-pump technique for surgical revascularization in patients with severe leftventricular dysfunction: the experience of a single center. J Cardiothorac Surg.2017;12(1):11. doi: 10.1186/s13019-017-0572-x.

  13. Samuels L, Stella A, Raws S, Arce A. Pump-Assisted Direct Coronary Artery Bypass(PAD- CAB) in Patients with Low Ejection Fraction: Potential Advantages.Cardiovascular Surgery International. 2022;3: Article1018. Available at: https://www.medtextpublications.com/open-access/pump-assisted-direct-coronary-artery-bypass-padcab-in-patients-with-low-1091.pdf. Last access: July 21, 2023.

  14. Perrault LP, Menasché P, Peynet J, et al. On-pump, beating-heart coronary arteryoperations in high-risk patients: an acceptable trade-off? Ann Thorac Surg.1997;64(5):1368-73. doi: 10.1016/S0003-4975(97)00842-4.

  15. Hwang B, Williams ML, Tian DH, Yan TD, Misfeld M. Coronary artery bypasssurgery for acute coronary syndrome: A network meta-analysis of on-pump cardioplegicarrest, off-pump, and on-pump beating heart strategies. J Card Surg.2022;37(12):5290-5299. doi: 10.1111/jocs.17149.

  16. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonanceimaging to identify reversible myocardial dysfunction. N Engl J Med.2000;343(20):1445-53. doi: 10.1056/NEJM200011163432003.

  17. Molchanova-Cook O, Chen W. Role of FDG-PET in Evaluation of MyocardialViability. PET Clin. 2011;6(4):383-91. doi: 10.1016/j.cpet.2011.08.003.

  18. Cholley B, Caruba T, Grosjean S, et al. Effect of Levosimendan on Low CardiacOutput Syndrome in Patients with Low Ejection Fraction Undergoing CoronaryArtery Bypass Grafting with Cardiopulmonary Bypass: The LICORN RandomizedClinical Trial. JAMA. 2017;318(6):548-556. doi: 10.1001/jama.2017.9973.

  19. Mehta RH, Leimberger JD, van Diepen S, et al; LEVO-CTS Investigators. Levosimendanin Patients with Left Ventricular Dysfunction Undergoing CardiacSurgery. N Engl J Med. 2017;376(21):2032-2042. doi: 10.1056/NEJMoa1616218.

  20. Landoni G, Lomivorotov VV, Alvaro G, et al; CHEETAH Study Group. Levosimendanfor Hemodynamic Support after Cardiac Surgery. N Engl J Med.2017;376(21):2021-2031. doi: 10.1056/NEJMoa1616325.

  21. Ramzy D, Soltesz E, Anderson M. New Surgical Circulatory Support System Outcomes.ASAIO J. 2020;66(7):746-752. doi: 10.1097/MAT.0000000000001194.

  22. Kawashima D, Gojo S, Nishimura T, et al. Left ventricular mechanical supportwith Impella provides more ventricular unloading in heart failure than extracorporealmembrane oxygenation. ASAIO J. 2011;57(3):169-76. doi: 10.1097/MAT.0b013e31820e121c.




2020     |     www.medigraphic.com